Danaher Co. (NYSE:DHR) Shares Sold by Paradigm Financial Partners LLC

Paradigm Financial Partners LLC decreased its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 90.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,267 shares of the conglomerate's stock after selling 11,496 shares during the period. Paradigm Financial Partners LLC's holdings in Danaher were worth $293,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in DHR. Nicholas Hoffman & Company LLC. raised its position in Danaher by 2.3% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate's stock worth $439,000 after purchasing an additional 43 shares during the period. Drive Wealth Management LLC boosted its holdings in Danaher by 3.1% during the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate's stock valued at $344,000 after acquiring an additional 44 shares during the period. Trust Investment Advisors grew its position in Danaher by 1.8% in the 4th quarter. Trust Investment Advisors now owns 2,811 shares of the conglomerate's stock valued at $650,000 after acquiring an additional 49 shares during the last quarter. Connolly Sarah T. increased its stake in Danaher by 0.5% in the third quarter. Connolly Sarah T. now owns 9,599 shares of the conglomerate's stock worth $2,382,000 after purchasing an additional 50 shares during the period. Finally, Austin Private Wealth LLC lifted its position in shares of Danaher by 3.4% during the third quarter. Austin Private Wealth LLC now owns 1,566 shares of the conglomerate's stock worth $389,000 after purchasing an additional 51 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on DHR. StockNews.com lowered shares of Danaher from a "buy" rating to a "hold" rating in a report on Wednesday, January 31st. Citigroup boosted their price target on Danaher from $280.00 to $290.00 and gave the company a "buy" rating in a report on Wednesday, April 24th. TD Cowen raised their price objective on Danaher from $280.00 to $290.00 and gave the stock a "buy" rating in a report on Wednesday, April 24th. Robert W. Baird lifted their target price on Danaher from $259.00 to $271.00 and gave the company an "outperform" rating in a research report on Wednesday, April 24th. Finally, Bank of America increased their price target on Danaher from $258.00 to $270.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $269.64.

Insider Activity

In other news, SVP Georgeann Couchara sold 2,622 shares of the stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the transaction, the senior vice president now directly owns 4,244 shares of the company's stock, valued at $1,029,891.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, SVP Georgeann Couchara sold 2,622 shares of the company's stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the sale, the senior vice president now directly owns 4,244 shares of the company's stock, valued at approximately $1,029,891.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Brian W. Ellis sold 4,000 shares of the firm's stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the transaction, the senior vice president now directly owns 29,830 shares of the company's stock, valued at approximately $7,457,798.30. The disclosure for this sale can be found here. Insiders have sold a total of 106,565 shares of company stock worth $26,641,364 over the last 90 days. 11.10% of the stock is currently owned by corporate insiders.

Danaher Stock Up 0.1 %

NYSE:DHR traded up $0.24 during midday trading on Monday, reaching $246.82. 1,615,251 shares of the stock traded hands, compared to its average volume of 2,771,678. The stock has a market capitalization of $182.82 billion, a PE ratio of 41.83, a price-to-earnings-growth ratio of 3.80 and a beta of 0.83. Danaher Co. has a 12-month low of $182.09 and a 12-month high of $259.00. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The business has a 50-day moving average of $248.80 and a two-hundred day moving average of $231.53.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.62 billion. During the same quarter in the prior year, the business posted $2.36 EPS. The business's revenue for the quarter was down 2.6% compared to the same quarter last year. On average, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were paid a dividend of $0.27 per share. This is a positive change from Danaher's previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher's payout ratio is presently 18.31%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.